Development Asset Leader, Liver Franchise
Core
Lead in vivo LNP-delivered liver gene editing programs from IND acceptance through regulatory approval/licensure, managing cross-functional teams and external partners.
Role type
VP, Development Asset Leader (Franchise)
Builds
Clinical-stage gene editing therapies for liver diseases (Wilson's Disease, Alpha-1 Antitrypsin Deficiency)
Domain
Biotechnology, Gene Editing, Liver Therapeutics
Required skills
Drug development leadership, Clinical trial design, Regulatory strategy, Cross-functional team management, CRO/CDMO management, Risk management, Budget management, Stakeholder engagement, AI-enabled project management, Strategic planning
Preferred skills
Genetic medicines experience, Rare disease experience, Liver-directed therapy experience, LNP delivery experience, AI tools for portfolio management
Technologies
AI-enabled project management tooling
Responsibilities
Own the Integrated Development Plan, Anticipate and escalate risk/value considerations, Lead matrixed cross-functional teams, Deploy AI-enabled project management tooling, Design team structure and governance, Serve as key point of contact with external partners
Seniority
VP, Strategic & Operational Leadership
